Medicenna Therapeutics Operating Expenses Growth & History (MDNAF)

Medicenna Therapeutics's operating expenses was $22.4M for fiscal 2026.

View full Medicenna Therapeutics company overview

Medicenna Therapeutics annual operating expenses history

Medicenna Therapeutics annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20262026-03-31$22.4M$2.0M+9.85%
20252025-03-31$20.4M$1.7M+9.27%
20242024-03-31$18.7M$2.4M+14.54%
20232023-03-31$16.3M−$6.2M−27.46%
20222022-03-31$22.5M$5.1M+29.19%
20212021-03-31$17.4M$9.2M+110.98%
20202020-03-31$8.2M

Medicenna Therapeutics operating expenses trends

Over the last five fiscal years, Medicenna Therapeutics's operating expenses increased from $17.4M to $22.4M, a change of $5.0M. The latest reported quarter, Q1 2027, shows $5.5M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Medicenna Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about MDNAF yet. Start the conversation.

Write the first post